Breaking News

KitoZyme appointed François Blondel as the new chief executive officer

February 13, 2013


• KitoZyme: appointed François Blondel as the new chief executive officer of the company. He was also appointed to the KitoZyme board of directors.

Prior to joining KitoZyme, Blondel has gained broad experience in the management of innovation driven companies. He started his career in the chemical and oil and gas sectors, with assignments both in the US and in Europe. In 1999, he joined International Brachytherapy (IBt), a startup in the medical device sector focused on cancer treatment. He served as CEO, leading IBt, a Euronext stock listed company, from its R&D stage to a successful and well-diversified international group and European leader in its sector.

Today, he is also serving as a board member of Compagnie du Bois Sauvage (diversified holding company listed on Euronext), Sopartec (holding of UCL university spinoffs), Nanocyl (world leader in production of carbon nanotubes), and a number of other companies active in the technology sector.

blog comments powered by Disqus
  • Innovation On Display

    Melissa Meisel, Associate Editor||February 3, 2016
    P&G Beauty Digital Studio showcases new products for 2016

  • Crowning Glory

    Crowning Glory

    Christine Esposito , Associate Editor||February 3, 2016
    Celebrity stylists and experts from leading hair care brands talk about the ingredients and formats driving the styling sector.

  • Electric Slide

    Electric Slide

    Melissa Meisel, Associate Editor||February 3, 2016
    Skin care devices bring anti-aging to the next level